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Thiopental, a thiobarbiturate which partitions prefentially into the hydrophobic environment, inhibited 
transport of amino acid neurotransmitters, CABA, aspartate and glutamate, and of biogenic amine, dopa- 
mine, across the synaptosomal membrane. At a given protein and thiopental concentration GABA trans- 
port was more sensitive to the barbiturate than were the movements of aspartate and glutamate although 
the uptake of each amino acid was inhibited essentially to the same extent as was its K+-stimulated release. 
By contrast, inhibition of dopamine uptake was larger than that of its release. Thiopental also inhibited 
the release of amino acid neurotransmitters caused by anaerobiosis. It is suggested that the barbiturate mo- 
difies the properties of the synaptosomal lipids and/or hydrophobic segments of proteins and thereby, simul- 
taneously and independently, affects various membrane functions. The equal inhibition of uptake and re- 
lease of amino acid neurotransmitters is consistent with the postulate that their transport occurs through 
the reversible membrane carriers which function efficiently in both the inward and outward directions. 
Thiopental Amino acid transport GABA Aspartate Glutamate Dopamine 
1. INTRODUCTION 
It has long been known that barbiturates depress 
synaptic excitatory transmission [1,2] and enhance 
synaptic inhibitory mechanisms [3-51 in the mam- 
malian central nervous system. The first of these 
phenomena occurs predominantly by a presynaptic 
decrease in the amount of neurotransmitter e- 
leased [1,2,6-81 whereas enhancement of the 
synaptic inhibitory mechanisms takes place at both 
pre- [5,9] and postsynaptic [4,10,1 l] sites. 
Barbiturates have also been reported to exert 
marked protective effects in cerebral hypoxia and 
ischemia (e.g., [ 12,131). Synapses are particularly 
vulnerable to the Iack of oxygen [14] and our 
studies have shown that the synaptic high-affinity 
uptake systems for the two putative excitatory 
amino acid neurotransmitters, glutamate and 
aspartate, which are responsible for termination of 
transmission modulated by these amino acids, 
were markedly inhibited by conditions mimicking 
hypoxia and ischemia [15]. Since these two ex- 
citatory amino acids have been suggested to act as 
neurotoxins [ 161, their increased levels in the 
synaptic cleft, caused by a damage to the transport 
proteins, could substantially contribute to irrever- 
sible neuronal damage. The objective of this in- 
vestigation was to test the possibility that protec- 
tive effects of barbiturates in hypoxia and ischemia 
are exerted, at least in part, through their inhibi- 
tion of release of aspartate and giutamate. 
2. MATERIALS AND METHODS 
* On leave of absence from Medical Research Centre, 
Polish Academy of Sciences, 3 Dworkowa Street, 
Warsaw, Poland 
Mate Sprague-Dawley rats were used through- 
out. Synaptosomes were isolated on discontinuous 
Ficoll gradients as in [ 171. The final pellet was 
suspended in a modified Krebs-Henseleit buffer 
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(140 mM NaCl, 5 mM KCl, 10 mM Tris-Hepes, 
5 mM NaHC03, 1.3 mM MgC12, 1 mM NaHP04 
and 1.25 mM CaCl$, pH 7.4, containing 10 mM 
glucose. 
Incubations were carried out as in [ 181. The rates 
of neurotransmitter uptake and release were deter- 
mined using radiolabeled derivatives [ 181. Amino 
acids were measured by high-pressure liquid 
chromatography (HPLC) [ 151 and determinations 
of intrasynaptosomal potassium and calcium were 
made as in [ 191. Protein was assayed according to 
WI. 
3. RESULTS 
3.1. Effect of thiopental on amino acid release 
caused by anaerobiosis and high K+ 
The effect of thiopental on the release of 
putative amino acid neurotransmitters, GABA, 
aspartate and glutamate, was evaluated by measur- 
ing concentrations of these amino acids in super- 
natants from synaptosomes incubated either 
anaerobically or in the presence of 50 mM 
potassium. Table 1 shows that anaerobiosis in- 
creased the concentration of aspartate in the super- 
natant by 3.7-fold, that of glutamate by 4.5-fold 
and GABA by 1 l-fold. In samples incubated with 
thiopental the respective rises in external amino 
acids were considerably smaller (2.4-, 4.4- and 
3.8-fold), the largest effect being seen with GABA 
and smallest with glutamate. Similar calculations 
for synaptosomes treated with 50 mM K+ (last col- 
umn in table 1) showed that thiopental was most 
effective in decreasing the depolarization-induced 
GABA release and least potent in preventing 
glutamate release. When veratridine (20pM) was 
used to depolarize synaptosomal membrane by 
opening the Na+ channels the results obtained were 
very similar to those with high potassium. 
Changes in the external concentrations of 16 
other amino acids were unaffected by the presence 
of thiopental (not shown). 
3.2. Effect of protein concentration on the 
inhibitory effects of thiopental 
It was noted that inhibition of release of 
neurotransmitter amino acids by thiopental was 
dependent on the amount of protein in the incuba- 
tion mixture. Therefore the effect of thiopental 
concentration on the release of [14C]GABA and 
[3H]aspartate was investigated on the same synap- 
tosomal suspension at a constant protein concen- 
tration and compared with the influence of the 
barbiturate on the rates of uptake of these two 
amino acids. Representative curves of uptake and 
release are shown in fig.1 and the summary of the 
results is given in table 2. Four aspects of the data 
are of interest: (i) thiopental caused inhibition of 
Table 1 
Effect of thiopental on the release of amino acid neurotransmitters caused by anaerobiosis and high K+ 









ap < 0.01 
2.3 + 0.7 2.1 f 0.6 8.5 f 1.6 5.1 * 0.9a 14.1 + 2.4 8.1 + l.3a 
4.2 f 0.9 3.8 + 0.7 19.1 * 3.1 16.6 + 2.4= 25.9 + 3.1 17.0 * 2.0a 
0.4 * 0.13 0.42 rt 0.1 4.4 + 1.2 1.6 k O.Sa 5.1 f 0.6 2.6 + 1.0” 
Synaptosomes were suspended at 1.5-2 mg protein/ml in Krebs-Henseleit medium, pH 7.3, containing 10 mM glucose 
and then divided into 3 parts. The first was incubated aerobically with and without 1 mM thiopental, the second was 
incubated anaerobically with and without thiopental, the third group was treated essentially like the first but the medium 
was supplemented with 50 mM K+. All incubations were carried out for 40 min at 25°C. At the end of the incubation, 
30021 aliquots were withdrawn and centrifuged (Beckman microfuge) through a layer of silicone oil to separate 
synaptosomes from the external medium. The upper layer, containing the external medium, was pipetted off, acidified 
with trichloroacetic acid (3% final concentration) and used for the measurements of amino acids by HPLC. Values are 
presented as concentrations @M) in the supernatants (means + SD for 3 experiments). Results were evaluated 
statistically (paired t-test) within each group (i.e., with respect to samples incubated without thiopental) 
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Fig. 1. The effect of thiopental on uptake and release of GABA and aspartate. (Uptake) Synaptosomes were diluted to 
1.2 mg protein/ml in Krebs-Henseleit buffer (pH 7.4) with and without 1 mM thiopental and uptake started by the 
addition of 2 PM [14C]GABA and 2 pM D-[3H]aspartate at 27°C. (Thiopental was always added immediately after the 
protein.) Aliquots (200 ~1) were removed at the times indicated and rapidly centrifuged (Beckman microfuge) through 
a layer of silicone oil. Radioactivity was then measured in the pellets. (Release) Synaptosomes were preloaded with the 
amino acids by incubation for 20 min at 27°C with 2gM [14C]GABA and 2pM D-[3H]aspartate. Aliquots were 
withdrawn and diluted IO-fold (to about 1.2 mg protein/ml) into Krebs-Henseleit buffer containing 70 mM K+, with 
and without 1 mM thiopental. Samples (200~1) were removed and rapidly centrifuged through a layer of silicone oil. 
Radioactivity was then determined in the supernatants. 
release as well as of uptake of the two amino acid 
neurotransmitters; (ii) inhibition increased with in- 
creasing concentration of thiopental; (iii) inhibi- 
tion of uptake and release at a given concentration 
of thiopental was approximately the same; (iv) in- 
hibition of aspartate uptake and release at the 
same barbiturate concentration was smaller than 
that of GABA. (Detailed kinetic evaluation of the 
inhibition of [14C]GABA uptake by thiopental 
showed it to be competitive with respect to the 
amino acid with an apparent Ki of 1.0 mM.) 
Since it can be argued from the results in table 
2 that uptakes of radioactive GABA and aspartate 
were somewhat less inhibited than their releases we 
have measured the rates of net GABA uptake using 
HPLC. This method avoids possible interference 
from homoexchange which is a substantial compo- 
nent of the measured rates of uptake of radioactive 
amino acids. GABA (2 ,uM) was added at time zero 
to samples incubated at 1 mg protein/ml with and 
without 1 mM thiopental and aliquots were 
withdrawn at 20, 60 and 240 s to measure GABA 
concentration in the supernatants. 20 s after addi- 
tion of the amino acid its level in control samples 
was 2.1 f 0.36 ,uM and in incubations with 
thiopental it was 2.08 f 0.23 PM (means f SD for 
3 experiments). After 4 min incubation, the respec- 
tive levels were 1.44 +- 0.22 and 1.81 -c 0.15 ,uM. It 
can be calculated that in the absence of thiopental 
the concentration of GABA in the supernatant (ex- 
ternal medium) decreased by 0.66rM whereas in 
its presence it declined by 0.27 PM, which 
251 
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Table 2 
Concentration dependence of thiopental inhibition of 




[Thiopental] % Inhibition 
(mM) 
Uptake Release 
0.25 8.2 + 3.4 17 -t 1.8 
0.5 22 34 f 4.6 
1.0 50 *18 58 f 12 
ASP 0.25 5.1 * 1.3 11 f 3.6 
0.5 13 20 f 6.1 
1.0 29 ?ll 45 f 16 
Uptake and release of [14C]GABA and D-[‘Hlaspartate 
were measured as described in the legend to fig. 1, in the 
incubation mixtures containing 1 + 0.1 mg 
synaptosomal protein/ml. Both amino acids were added 
simultaneously to the synaptosomal suspensions. 
Inhibition (vo) was calculated from the slopes of the 
initial (20-180 s) linear parts of the uptake or release 
curves. Values are means f SD for 3 experiments except 
where SD is not given 
represents a 60% inhibition of uptake. (The dif- 
ferences between the two sets of experimental 
values were significant at a level of P 0.01, as 
evaluated by the paired Student’s t-test.) This 
value is in excellent agreement with the 58% inhibi- 
tion of GABA release shown in table 2 and ob- 
tained at the same thiopental and protein 
concentrations. 
3.3. Effect of thiopental on dopamine transport 
The effect of thiopental on the uptake and 
release of radioactive dopamine was measured at 
1 mg protein/ml and with 1 mM barbiturate. The 
uptake was inhibited by 41 f 6.6% whereas the 
release was decreased by only 10 + 4% (means + 
SD for 9 experiments). The inhibition of uptake by 
thiopental was kinetically competitive with respect 
to dopamine with an apparent Ki of 0.9 mM. 
3.4. Effect of thiopental on intrasynaptosomal 
potassium and calcium 
Thiopental(1 mM) had no effect on intrasynap- 
tosomal potassium concentration. Hence the 
transmembrane electrical potential, which in the 
synaptosomes is the K+ diffusion potential [21], 
252 
was unaltered. On the other hand, the barbiturate 
eliminated almost completely stimulation of 
calcium accumulation by synaptosomes depola- 
rized with 50 mM K+, in agreement with the results 
of others [22,23]. 
3.5. Effect of thiopental on the synaptosomal 
membrane 
A fluorescent probe of the hydrophobic region 
of the membrane, 1,6-diphenyl-1,3,5_hexatriene 
[24], was used to measure the effect of thiopental 
on synaptosomal membranes. The results of 3 in- 
dependent experiments carried out at about 1 mg 
protein/ml showed that as the thiopental concen- 
tration was increased the anisotropy of the probe’s 
fluorescence decreased: it was 0.252 + 0.011 
(mean f SD) at 0 thiopental, 0.214 f 0.003 at 
1 mM thiopental and 0.171 f 0.005 at 2 mM 
thiopental. Since there was no change in the 
fluorescence lifetime (not shown) this decrease in 
the anisotropy indicates that the environment of 
the probe became progressively more fluid with in- 
creasing barbiturate. 
4. DISCUSSION 
Our results show that thiopental, a thiobar- 
biturate which partitions preferentially into the 
hydrophobic environment, inhibits transport of 
various neurotransmitters across the synaptosomal 
membrane as well as other membrane functions. 
The effect of thiopental was markedly dependent 
on the barbiturate and protein concentrations in 
the incubation mixture and at a given barbiturate 
concentration various processes exhibited different 
sensitivities to its action. This observation may ex- 
plain some of the conflicting reports in which the 
same reactions were observed to be either sensitive 
or insensitive to barbiturate inhibition [9,25-271. 
At a given protein and thiopental concentration 
the barbiturate inhibited movements of both the 
amino acid neurotransmitters and of dopamine but 
with different characteristics. The inhibition of up- 
takes of GABA, aspartate and glutamate required 
essentially the same thiopental concentration as 
blockage of their releases. This observation sup- 
ports our postulate [28,29] that movements of 
amino acid neurotransmitters across the synap- 
tosomal membrane occurs through the operation 
of reversible membrane carriers which function ef- 
Volume 177, number 2 FEBS LETTERS November 1984 
ficiently in either inward or outward directions. By 
contrast, the uptake of dopamine was considerably 
more sensitive to thiopental inhibition than was its 
release, consistent with the generally espoused view 
that uptake of biogenic amines by the nerve 
endings occurs through a membrane carrier 
whereas its release is primarily an exocytotic pro- 
cess [30]. 
gest that the effects modulated through calcium re- 
quire higher concentrations of thiopental than 
those exerted directly on the membrane. 
The high-affinity uptake systems for GABA, 
acidic amino acids and dopamine are mediated by 
different membrane proteins. Hence inhibition of 
all these reactions implies that a common 
mechanism may be involved. Two possibilities can 
be entertained to explain the findings. The first is 
that thiopental, like other barbiturates, modifies 
properties of the synaptosomal membrane which, 
in turn, affects operation of various membrane 
functions. Such suggestions have been made [6,31] 
and our studies with the fluorescent probe seem to 
support this interpretation. However, it should be 
mentioned that although our results as well as 
those of others (e.g., [32]) indicate that bar- 
biturates increase membrane fluidity, these com- 
pounds may also modify the hydrophobic 
segments of membrane proteins. Differential sen- 
sitivity of the various transport systems to thiopen- 
ta1 at the same inhibitor and protein concentra- 
tions appears to be in agreement with the latter 
suggestion. The second possibility is that thiopen- 
ta1 acts through a common effector of the 
neurotransmission event. It has been postulated 
that calcium fulfills such a role [33,34]. However, 
calcium is not required for uptake of various 
neurotransmitters, nor does its absence substan- 
tially inhibit amino acid release in our synap- 
tosomal preparation [29]. These observations 
argue against calcium being responsible for the ef- 
fects of thiopental on the movements of amino 
acid neurotransmitters. On the other hand, 
calcium influx caused by high potassium-induced 
membrane depolarization was inhibited by the bar- 
biturate. Moreover, dopamine release, which is 
very sensitive to the presence of Ca2+, was de- 
pressed by the anesthetic although to a much 
smaller extent than was the amine uptake. It is 
therefore tempting to postulate that blocking of 
calcium influx and consequences thereof con- 
tribute, to some extent, to the effects of bar- 
biturates observed in this and other (e.g., 
[12,13,15]) studies. However, our results also sug- 
The differential sensitivity of the 3 amino acid 
neurotransmitter uptake systems to thiopental is 
an interesting observation. Although the forces 
responsible for the maintenance of their concentra- 
tion gradients across the synaptosomal membrane 
and hence their movements in both directions, are 
the same, GABA transport was much more sen- 
sitive to thiopental inhibition than were 
movements of aspartate and glutamate (see also 
[9]). This observation suggests that there are other 
mechanism(s) in addition to those mentioned 
above, which control movements of individual 
amino acid neurotransmitters. Whether this (these) 
mechanism(s) reside(s) in the membrane itself or is 
(are) exerted through intracellular second 
messengers remains to be established. 
Finally, we have also shown that thiopental in- 
hibits release of amino acid neurotransmitters 
caused by anaerobiosis. Since neurotransmission 
depends on the rate with which transmitters are 
released into the synaptic cleft our results mean 
that thiopental, by decreasing this rate, will lower 
the effective neurotransmitter concentration in 
response to the stimulus. If the concentration in 
the synaptic cleft falls below the threshold value, 
transmission may not even occur which, in the case 
of excitatory amino acids, will result in an overall 
suppression of electrical activity. 
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